LETROZOLE CIPLA letrozole 2.5mg film-coated tablet blister pack
देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
सार्वजनिक आकलन रिपोर्ट
(PAR)
25-11-2017
अनुरोध भेजा।
सक्रिय संघटक:
letrozole, Quantity: 2.5 mg
थमां उपलब्ध:
Cipla Australia Pty Ltd
INN (इंटरनेशनल नाम):
Letrozole
फार्मास्यूटिकल फॉर्म:
Tablet, film coated
रचना:
Excipient Ingredients: lactose monohydrate; sodium starch glycollate; microcrystalline cellulose; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; iron oxide yellow; macrogol 400
प्रशासन का मार्ग:
Oral
पैकेज में यूनिट:
30, 10
प्रिस्क्रिप्शन प्रकार:
(S4) Prescription Only Medicine
चिकित्सीय संकेत:
For the treatment of postmenopausal women with hormone receptor positive breast cancer (see Clinical Trials). The safety and efficacy of neoadjuvant use of letrozole has not been established. Letrozole is not indicated in hormone receptor negative disease.
उत्पाद समीक्षा:
Visual Identification: Yellow circular, biconvex, film coated tablet debossed with LT on one side and 2.5 on the other side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
प्राधिकरण का दर्जा:
Licence status A
प्राधिकरण की तारीख:
2016-06-01
